Ambit Biosciences' Series D Round

Ambit Biosciences raised a round of funding on November 12, 2007.

Ambit Biosciences is a biopharmaceutical company engaged in the development of a robust pipeline of small molecule kinase inhibitors for the treatment of cancer, inflammatory disease and other indicat…

Articles about Ambit Biosciences' Series D Round: